2016
DOI: 10.1007/s10384-016-0484-7
|View full text |Cite
|
Sign up to set email alerts
|

In vivo imaging of a cone mosaic in a patient with achromatopsia associated with a GNAT2 variant

Abstract: This is the first description of a Japanese patient with ACHM with a novel GNAT2 variant. The eyes of this patient had a preserved cone structure with loss of function.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
14
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 31 publications
0
14
1
Order By: Relevance
“…There are reports of congenital achromatopsia, which shows similar pattern such as cone dysfunction in the ERG, loss of IZ in the OCT, and D-15 abnormality with confusion lines between deutan and tritan. 77,78 The course of our cases was progressive and was not like that of congenital achromatopsia. However, the relationship between the results of color vision tests and OCT images could not be revealed.…”
Section: Discussionmentioning
confidence: 64%
“…There are reports of congenital achromatopsia, which shows similar pattern such as cone dysfunction in the ERG, loss of IZ in the OCT, and D-15 abnormality with confusion lines between deutan and tritan. 77,78 The course of our cases was progressive and was not like that of congenital achromatopsia. However, the relationship between the results of color vision tests and OCT images could not be revealed.…”
Section: Discussionmentioning
confidence: 64%
“…In 2002, we reported five families with patients affected by ACHM caused by mutations in GNAT2 (Kohl et al, ; Rosenberg et al, ). Since then only few reports of single families have been published (Aligianis et al, ; Piña, Baumert, Loyer, & Koenekoop, ; Ouechtati et al, ; Langlo et al, , Taylor et al, ; Carss et al, ; Ueno et al, ). Herein we report the results of our genetic investigation of our complete ACHM cohort over a period of 16 years, in total identifying 23 affected individuals from 19 independent families carrying likely disease‐causing mutations in GNAT2 , of which 12 mutations have never been reported before.…”
Section: Introductionmentioning
confidence: 99%
“…23,24 The GNAT2-ACHM genotype is associated with the relatively least disrupted photoreceptor mosaic. 6,20 Simultaneous confocal and splitdetection AOSLO has allowed the identification of cone inner segment structure in the previously described "dark spaces." [25][26][27][28] GNAT2-ACHM was only investigated with confocal AOSLO imaging in two pedigrees to date.…”
mentioning
confidence: 99%
“…[25][26][27][28] GNAT2-ACHM was only investigated with confocal AOSLO imaging in two pedigrees to date. 6,20 CNGB3 and CNGA3 are responsible for 70% of the reported ACHM cases and are the most well studied genotypes, with on-going gene therapy trials (ClinicalTrials.gov numbers: NCT03758404, NCT02935517 NCT03001310, NCT02599922, and NCT02610582). Three homologous mouse models of GNAT2-ACHM have been described to date.…”
mentioning
confidence: 99%